US

Zenflow secures $6 mln credit facility from Square 1 Bank

Square 1 Bank, a unit of Pacific Western Bank, has provided a $5 million credit facility to South San Francisco-based Zenflow, a urologic medical device company. The financing will be used to support Zenflow's growth initiatives. Zenflow's backers include F-Prime Capital Partners, Invus Opportunities, Medical Technology Venture Partners, Y Combinator and the Stanford-StartX Fund.

Antios scores $25 mln Series A

Antios Therapeutics Inc, a biopharmaceutical company, has secured $25 million in Series A financing. Lumira Ventures and Domain Associates led the round.

INKEF appoints Bulthuis as MD and head of healthcare team

INKEF Capital, a Dutch venture firm, has named Roel Bulthuis as managing director and head of healthcare team. Previously, he worked at M Ventures.

ISIF, WuXi and GMI launch $400 mln program to boost Ireland as genomics research hub

The Ireland Strategic Investment Fund, WuXi NextCODE and Genomics Medicine Ireland have launched a $400 million investment program aimed at making Ireland a hub for genomics research and development of new disease treatments and cures. The other investors in this initiative include ARCH Venture Partners, Polaris Partners, Temasek, Yunfeng Capital and Sequoia Capital.

VC-backed Rgenix expands board with new addition

New York City-based Rgenix, Inc, a developer of small molecule and antibody cancer therapeutics, has named Dr. Peter Van Vlasselaer to its board of directors. Recently, he was the president and CEO of ARMO Biosciences. Rgenix's backers include Novo A/S, Sofinnova Partners, Lepu Medical, Oceanpine Capital, WuXi AppTec’s Corporate Venture Fund, Alexandria Venture Investments and the Partnership Fund for New York City’s Innovate NY Fund.

Signal Peak Ventures taps Dahl as MD

Signal Peak Ventures has appointed Ben Dahl as a managing director. Previously, Dahl worked at Pelion Venture Partners where he was a partner.

Frazier Healthcare Partners recruits Hancock as senior adviser

Frazier Healthcare Partners has named Dr. Mimi Hancock to its life sciences team as a senior adviser. Previously, she was a member of Spencer Stuart's life sciences practice.

Oral health company Quip picks up $40 mln

Brooklyn, New York-based Quip, an oral health company, has secured $40 million in funding. The lead investor was Sherpa Capital.

Keyto raises $2.5 mln

Keyto said Nov. 27 that it closed a $2.5 million seed round led by David Sacks’ Craft Ventures. Also participating were Floodgate Fund, Abstract Ventures and Hydra Ventures as well as entrepreneurs Julia Hartz (Eventbrite co-founder and CEO) and Kevin Hartz (Eventbrite co-founder and early investor in Pinterest, PayPal and Airbnb). Keyto, of San Francisco, is a health and wellness company that provides a smart breath sensor that can detect when the body is in ketosis.

Technology Impact Growth Fund seeks $200 mln

Palo Alto, California-based Technology Impact Growth Fund is raising $200 million, according to a regulatory filing. Listed as the fund's managers are Dipender Saluja and Ion Yadigaroglu. The two are partners at the Capricorn Investment Group, an investment firm formed by former eBay President Jeffrey Skoll.